Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab.
Affiliation
Department of Critical Care, The Christie, Manchester, UK. cooks199@hotmail.comIssue Date
2011-09
Metadata
Show full item recordAbstract
Posterior reversible encephalopathy syndrome (PRES) is a combined clinical and radiological syndrome characterised by headaches, encephalopathy, seizures and visual loss. We present the case of a 55-year-old male who developed this condition following treatment with deoxycoformycin and alemtuzumab. We review the literature considering diagnosis, pathophysiology and optimal strategies for treatment of this condition.Citation
Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab. 2011, 41 (3):215-7 J R Coll Physicians EdinbJournal
Journal of the Royal College of Physicians of EdinburghDOI
10.4997/JRCPE.2011.306PubMed ID
21949916Type
ArticleLanguage
enISSN
2042-8189ae974a485f413a2113503eed53cd6c53
10.4997/JRCPE.2011.306